Literature DB >> 20883082

Candida tropicalis in human disease.

Louis Yi Ann Chai1, David W Denning, Peter Warn.   

Abstract

Candida tropicalis is one of the more common Candida causing human disease in tropical countries; the frequency of invasive disease varies by geography causing 3--66% of candidaemia. C. tropicalis is taxonomically close to C. albicans and shares many pathogenic traits. C. tropicalis is particularly virulent in neutropenic hosts commonly with hematogenous seeding to peripheral organs. For candidaemia and invasive candidiasis amphotericin B or an echinocandin are recommended as first-line treatment, with extended-spectrum triazoles acceptable alternatives. Primary fluconazole resistance is uncommon but may be induced on exposure. Physicians in regions where C. tropicalis is common need to be mindful of this lesser-described pathogen.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20883082     DOI: 10.3109/1040841X.2010.489506

Source DB:  PubMed          Journal:  Crit Rev Microbiol        ISSN: 1040-841X            Impact factor:   7.624


  31 in total

1.  Stepwise development of a homozygous S80P substitution in Fks1p, conferring echinocandin resistance in Candida tropicalis.

Authors:  Rasmus Hare Jensen; Helle Krogh Johansen; Maiken Cavling Arendrup
Journal:  Antimicrob Agents Chemother       Date:  2012-10-22       Impact factor: 5.191

2.  Calcineurin controls hyphal growth, virulence, and drug tolerance of Candida tropicalis.

Authors:  Ying-Lien Chen; Shang-Jie Yu; Hsin-Yu Huang; Ya-Lin Chang; Virginia N Lehman; Fitz Gerald S Silao; Ursela G Bigol; Alice Alma C Bungay; Anna Averette; Joseph Heitman
Journal:  Eukaryot Cell       Date:  2014-01-17

3.  Candida tropicalis as a Predominant Isolate from Clinical Specimens and its Antifungal Susceptibility Pattern in a Tertiary Care Hospital in Southern India.

Authors:  Binesh Lal Yesudhason; Kalyani Mohanram
Journal:  J Clin Diagn Res       Date:  2015-07-01

4.  Rapid Detection and Differentiation of Clinically Relevant Candida Species Simultaneously from Blood Culture by Use of a Novel Signal Amplification Approach.

Authors:  Wanyuan Ao; Joshua Klonoski; Eric Berlinghoff; Jordan Jensen; Taliman Afroz; Denton Munns; Wes Lindsey; Gerald Denys; Robert Jenison
Journal:  J Clin Microbiol       Date:  2017-12-26       Impact factor: 5.948

Review 5.  How much do we know about hemolytic capability of pathogenic Candida species?

Authors:  Márcia C Furlaneto; Helena P Góes; Hugo F Perini; Renan C Dos Santos; Luciana Furlaneto-Maia
Journal:  Folia Microbiol (Praha)       Date:  2018-01-15       Impact factor: 2.099

6.  Proteogenomics of Candida tropicalis--An Opportunistic Pathogen with Importance for Global Health.

Authors:  Keshava K Datta; Arun H Patil; Krishna Patel; Gourav Dey; Anil K Madugundu; Santosh Renuse; Jyothi E Kaviyil; Raja Sekhar; Aryashree Arunima; Bhavna Daswani; Inderjeet Kaur; Jyotirmaya Mohanty; Ranjana Sinha; Sangeeta Jaiswal; S Sivapriya; Yeshwanth Sonnathi; Bharat B Chattoo; Harsha Gowda; Raju Ravikumar; T S Keshava Prasad
Journal:  OMICS       Date:  2016-04

7.  Candida tropicalis antifungal cross-resistance is related to different azole target (Erg11p) modifications.

Authors:  A Forastiero; A C Mesa-Arango; A Alastruey-Izquierdo; L Alcazar-Fuoli; L Bernal-Martinez; T Pelaez; J F Lopez; J O Grimalt; A Gomez-Lopez; I Cuesta; O Zaragoza; E Mellado
Journal:  Antimicrob Agents Chemother       Date:  2013-07-22       Impact factor: 5.191

8.  Nosocomial bloodstream Candida infections in a tertiary-care hospital in South Brazil: a 4-year survey.

Authors:  Viviane Gevezier da Costa; Regina Mariuza Borsato Quesada; Aline Tancler Stipp Abe; Luciana Furlaneto-Maia; Márcia Cristina Furlaneto
Journal:  Mycopathologia       Date:  2014-08-08       Impact factor: 2.574

9.  Pseudomembranous candidiasis in HIV/AIDS patients in Cali, Colombia.

Authors:  Luz Ángela Castro; María Inés Álvarez; Ernesto Martínez
Journal:  Mycopathologia       Date:  2012-10-21       Impact factor: 2.574

10.  Induction therapy for acute lymphoblastic leukemia: incidence and risk factors for bloodstream infections.

Authors:  Rosângela Aparecida Mendes Silva; Regina Maria Holanda de Mendonça; Simone Dos Santos Aguiar; Júlia Cervellini Yajima; Fernando Augusto Lima Marson; Silvia Regina Brandalise; Carlos Emílio Levy
Journal:  Support Care Cancer       Date:  2021-08-07       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.